51 / 144
331
43. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL,
Masdéu JC, García JH, et al. Vascular dementia: diagnostic
criteria for research studies. Report of the NINDS-AIREN
International Workshop. Neurology 1993; 43: 250-60.
44. Chui HC, Victorov JI, Margolin D, Jagust W, Shankle R,
Katzman R. Criteria for the diagnosis of ischemic vascular
dementia proposed by the State of California Alzheimer’s
Disease Diagnostic and Treatment Centers. Neurology
1992; 42: 473-480.
45. McPherson SE, Cummings JL. Neuropsychological aspects
of vascular dementia. Brain Cogn 1996 ; 31 : 269-82.
46. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions
impair frontal lobe function regardless of their location.
Neurology 2004 ; 63 : 246-53.
47. Rosen WG, Terry RD, Fuld PA et al. Pathological verification
of ischemic score in differenciation of dementia. Ann
Neurol. 1980;7(5):486-8.
48. Godefroy O, Groupe de réflexion pour l´évaluation des
fonctions executives. Fonctions Executives et pathologies
neurologiques et psychiatriques. Evaluation en pratique
clinique. Solal, Marseille, 2008.
49. Stewart, J. T. Psychiatric and behavioral manifestations of
vascular dementia. Am J Geriatric Cardiology 2007; 16(3),
165-170
50. Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P,
Barkhof F, van der Flier W M. Behavioural and psychological
symptoms in vascular dementia; differences between
small- and large-vessel disease. Journal of Neurology
Neurosurgery and Psychiatry 2010; 81(5), 547- 551.
51. Sahgal A, Galloway PH, McKeith IG, Edwardson JA, Lloyd
S. A comparative study of attentional deficits in senile
dementias of Alzheimer and Lewy body types. Dementia
1992; 3: 350–354.
52. Ayre G, Ballard C, Pincock C, McKeith I, Sahgal A, Wesnes
K. Double dissociation between dementia with Lewy
bodies and Alzheimer’s disease on tests of attentional
and mnemonic function: The role of the basal forebrain. J
Psychopharmacol 1998; A12 (Suppl.): A62–A68.
53. Oda Y, Yamamoto Y, Maeda K. Neuropsychological profile
of dementia with Lewy bodies. Psichogeriatrics 2009; 9:
85–9.
54. Hansen L, Salmon D, Galasko D et al. The Lewy body variant
of Alzheimer’s disease: A clinical and pathological entity.
Neurology 1990; 40: 1–8.
55. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in
Lewy body disease realte to Lewy bodies in the temporal
lobe. Brain 2002; 125, 391-403.
56. Parkinson J. 1817. An essay on the shaking palsy.
Whitting-ham and Rowland for Sherwood, Needly and
Jones, London.
57. Charcot J-M. 1872. De la paralysie agitante. In Oeuvres
Completes (t 1) Lecons sur les maladies du systeme nerveux,
pp. 155–188. A Delahaye, Paris. [In English: Charcot J-M.
1877. On Parkinson’s disease. In Lectures on diseases of the
nervous system delivered at the Salpetriere (transl. Sigerson
G), London. pp. 129 – 156. New Sydenham Society,
58. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive
profile of patients with newly diagnosed Parkinson disease.
Neurology 2005; 65: 1239-45.
59. Pfeiffer HC, Løkkegaard A, Zoetmulder M, Friberg L, Werdelin
L. Cognitive impairment in early-stage non-demented
Parkinson’s disease patients. Acta Neurol Scand 2014;
129: 307-18.
60. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh
MN, Hentz JG, Noble B, et al. Defining mild cognitive
impairment in Parkinson’s disease. Mov Disord 2007; 22:
1272-7.
61. Yu RL, Wu RM, Tai CH, Lin CH, Cheng TW, Hua MS.
Neuropsychological profile in patients with early stage of
Parkinson’s disease in Taiwan. Parkinsonism Relat Disord
2012; 18: 1067-72.
62. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J,
Mollenhauer B, et al. MDS Task Force on mild cognitive
impairment in Parkinson’s disease: critical review of
PD-MCI. Mov Disord 2011; 26: 1814-24.
63. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C,
Mizuno Y, et al. Clinical diagnostic criteria for dementia
associated with Parkinson’s disease. Mov Disord 2007; 22:
1689-707.
64. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe
GA, et al. Diagnostic procedures for Parkinson’s disease
dementia: recommendations from the Movement Disorder
Society task force. Mov Disord 2007; 22: 2314-24.
65. Kudlicka A, Clare L, MA, Hindle JV. Executive Functions in
Parkinson’s Disease: Systematic Review and Meta-Analysis
Mov Disord 2011; 26 (13): 2305-15.
66. Weintraub D, Burn DJ. Parkinson´s disease: the
quintessential neuropsychiatric disorder. Mov Disord 2011;
26(6): 1022-31.
67. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black
S, et al. Frontotemporal lobar degeneration: a consensus on
clinical diagnostic criteria. Neurology 1998 ; 51 : 1546-54.
68. Hodges JR, Patterson K, Ward R, et al. The differentiation of
semantic dementia and frontal lobe dementia (temporal
and frontal variants of frontotemporal dementia) from
early Alzheimer’s disease : a comparative neuropsycholical
study. Neuropsychology 1991; 13: 31-40.
69. Boutoleau-Bretonniere C, Lebouvier T, Vercelletto M. La
variante frontale de dégénérescence frontotemporale.
Geriatr Psychol Neuropsychiatr Vieil 2014; 12 (1) :63-73.
[El rol de la evaluación neuropsicológica en el diagnóstico y en el seguimiento de las demencias - Matías Molina D.]